Aspartame promotes ovarian cancer progression: A multi-omics study integrating mendelian randomization, network toxicology, and in vitro validation
Year: 2025
Type: article
Language: en
Topic: Biochemical Analysis and Sensing Techniques
Authors and affiliations:
raw_author_name: Qingquan Gong
raw_affiliation_strings: Guangxi Reproductive Medical Center, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, 530021, China
Guangxi Reproductive Medical Center, the First Affiliated Hospital of Guangxi Medical University, Nanning, China, 530021; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China, 530021
raw_author_name: Dingyu Liang
raw_affiliation_strings: Guangxi Reproductive Medical Center, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, 530021, China
Guangxi Reproductive Medical Center, the First Affiliated Hospital of Guangxi Medical University, Nanning, China, 530021; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China, 530021
raw_author_name: Yongjin Luo
raw_affiliation_strings: Guangxi Reproductive Medical Center, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, 530021, China
Guangxi Reproductive Medical Center, the First Affiliated Hospital of Guangxi Medical University, Nanning, China, 530021; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China, 530021
raw_author_name: Chao Yang
raw_affiliation_strings: Guangxi Reproductive Medical Center, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, 530021, China
Guangxi Reproductive Medical Center, the First Affiliated Hospital of Guangxi Medical University, Nanning, China, 530021; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China, 530021
raw_author_name: Yihua Yang
raw_affiliation_strings: Guangxi Reproductive Medical Center, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, 530021, China. Electronic address: workyyh@163.com
Guangxi Reproductive Medical Center, the First Affiliated Hospital of Guangxi Medical University, Nanning, China, 530021; Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Nanning, China, 530021. Electronic address: workyyh@163.com
raw_author_name: Shujie Zhang
raw_affiliation_strings: Guangxi Reproductive Medical Center, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China; Department of Genetics and Metabolism, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530021, China. Electronic address: zhangshujie1990@163.com
Guangxi Reproductive Medical Center, the First Affiliated Hospital of Guangxi Medical University, Nanning, China, 530021; Department of Genetics and Metabolism, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China, 530021